research Advances in structure-based drug design targeting membrane protein markers in prostate cancer
This review examines advances in computer-aided drug design for targeting membrane proteins in prostate cancer but reports no new clinical results; it emphasizes the potential of structural insights and compound screening for therapeutic development.

